정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1584 | Recruiting | Efficacy and Safety of Nitazoxanide for Post Exposure Prophylaxis of COVID-19 in Household Contacts | Households Contacts | Drug: Nitazoxanide Drug: Placebo |
Phase 4 | Fundacion Huesped, Ministerio de Salud de Ciudad Autonoma de Buenos Aires, Laboratorios Roemmers S.A.I.C.F. | OTHER | 456 | All | 18 Years ~ 65 Years | Fundacion Huesped., Buenos Aires, Ciudad Autonoma De Buenos Aires, Argentina |
| 1583 | Recruiting | Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 | COVID-19 | Drug: Nitazoxanide Tablets Drug: Placebo |
Not Applicable | Azidus Brasil, Farmoquimica S.A., Hospital Vera Cruz, Hospital Casa de Saude - Vera Cruz - Campinas - SP - Brazil, Centro de Genomas - UNIFESP, Emilio Ribas Institute of Infectious Diseases | INDUSTRY | 50 | All | 18 Years | Hospital Vera Cruz, Campinas, Sao Paulo, Brazil Centro de Genomas, Sao Paulo, Brazil Hospital Emilio Ribas, Sao Paulo, Brazil |
| 1582 | Recruiting | Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia | Viral Pneumonia | Biological: Convalescent anti-SARS-CoV-2 plasma Other: Infusion placebo |
Phase 3 | Thomas Benfield | OTHER | 1100 | All | 18 Years | Aalborg University Hospital, Aalborg, Denmark Aarhus University Hospital, Arhus, Denmark Bispebjerg Hospital, Copenhagen, Denmark Rigshospitalet, Copenhagen, Denmark Herlev Gentofte Hospital, Herlev, Denmark Herning Hospital, Herning, Denmark Nordsjællands Hospital, Hillerød, Denmark Hvidovre Hospital, Hvidovre, Denmark Kolding Hospital, Kolding, Denmark Odense University Hospital, Odense, Denmark Roskilde Hospital, Roskilde, Denmark Vejle Hospital, Vejle, Denmark |
| 1581 | Active, not recruiting | Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 | Infections, Coronavirus | Drug: azoximer bromide Other: Placebo |
Phase 3 | NPO Petrovax | INDUSTRY | 394 | All | 18 Years ~ 85 Years | Regional state budgetary institution of public health "City hospital No. 5 of Barnaul", Barnaul, Russian Federation Central Research Institute of Epidemiology of Rospotrebnadzor, Moscow, Russian Federation The state healthcare institution of the city of Moscow "City Clinical Hospital No. 15 named after OM Filatov" in "Moscow City Department of Health", Moscow, Russian Federation Moscow State Budgetary Healthcare Institution "Infectious Clinical Hospital No. 1 of the Moscow Department of Healthcare", Moscow, Russian Federation Moscow State Budgetary Healthcare Institution "City Clinical Hospital No. 24 of the Moscow Department of Healthcare", Moscow, Russian Federation State budgetary institution "Research Institute of Emergency Care named after N.V. Sklifosovsky in Department of Health of the city of Moscow", Moscow, Russian Federation Moscow State Budgetary Healthcare Institution "City Clinical Hospital No. 40 of the Moscow Department of Healthcare", Moscow, Russian Federation State budgetary institution of health care of the Nizhny Novgorod region "Infectious clinical hospital No. 2 of Nizhny Novgorod", Nizhny Novgorod, Russian Federation Federal State Budgetary Educational Institution of Higher Education "Orenburg State Medical University" of the Ministry of Health of the Russian Federation, Orenburg, Russian Federation Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after Academician I.P. Pavlov, Saint Petersburg, Russian Federation State budgetary health institution of the Vladimir region "Regional Clinical Hospital", Vladimir, Russian Federation Yaroslavl State Medical University of Ministry of Health of the Russian Federation, Yaroslavl, Russian Federation Clinics of Infectious Diseases, University Hospital in Nitra, Nitra, Slovakia Clinics of Infectious Diseases, University Hospital in Trnava, Trnava, Slovakia |
| 1580 | Recruiting | Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients | Covid19 | Biological: recovered covid 19 patients plasma | Early Phase 1 | South Valley University | OTHER | 30 | All | 18 Years | South Valley University, Qin?, Egypt |
| 1579 | Completed | Efficacy and Safety of Remdesivir and Tociluzumab for the Management of Severe COVID-19: A Randomized Controlled Trial | Covid-19 ARDS | Drug: Remdesivir Drug: Tocilizumab |
Phase 3 | M Abdur Rahim Medical College and Hospital, First Affiliated Hospital Xi'an Jiaotong University, Cox's Bazar 250 Bed District Sadar Hospital, Chattogram General Hospital | OTHER_GOV | 205 | All | 16 Years ~ 80 Years | Chattogram General Hospital, Chittagong, Bangladesh Cox's Bazar 250 Bed District Sadar Hospital, Cox's Bazar, Bangladesh M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh |
| 1578 | Recruiting | Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia | COVID-19 | Drug: Siltuximab Drug: Methylprednisolone |
Phase 2 | Judit Pich Martinez | OTHER | 200 | All | 18 Years | Hospital Germans Trias i Pujol, Badalona, Spain Hospital Clinic de Barcelona, Barcelona, Spain Hospital Universitario de Salamanca, Salamanca, Spain Hospital Universitari Mutua de Terrassa, Terrassa, Spain |
